P28 Impact of FDA Expedited Review Programs on New Drug Approval Time

Abstract

Authors

S. Ronnebaum D. Smith M. Andrawes

Full Text Cite This Article
Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×